Heterocyclic compound as protein kinase inhibitor
US8957102B2 · kind B2 · utility
3Cited by
0References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 28, 2009 |
| Grant date | Feb 17, 2015 |
| Priority date | — |
| Expiry date | Oct 22, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are novel heterocyclic compounds useful as anti-cancer drugs by suppressing protein kinase activities of growth factor receptors such as c-Met, pharmaceutical compositions containing the same, and methods for using the compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.